Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC

NCT02200081 ·Status: COMPLETED ·Phase: PHASE2

Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer

NCT03520686 ·Status: TERMINATED ·Phase: PHASE3

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

NCT02523469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors

NCT04571632 ·Status: UNKNOWN ·Phase: PHASE2

Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer

NCT03131037 ·Status: COMPLETED ·Phase: PHASE1

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT02410603 ·Status: COMPLETED

Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

NCT00017407 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)

NCT01358942 ·Status: COMPLETED

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab

NCT01814163 ·Status: COMPLETED

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NCT04807114 ·Status: RECRUITING

An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany

NCT06169956 ·Status: RECRUITING

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

NCT03048136 ·Status: WITHDRAWN ·Phase: PHASE3

The ACC Preclinical Research Platform for Precision Oncology

NCT06339541 ·Status: RECRUITING

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT01496742 ·Status: COMPLETED ·Phase: PHASE2

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

NCT04173325 ·Status: TERMINATED ·Phase: PHASE1

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

NCT03377023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

NCT02259621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

NCT03132493 ·Status: COMPLETED

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

NCT02847728 ·Status: COMPLETED

Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer

NCT00084981 ·Status: COMPLETED ·Phase: PHASE1

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

NCT03001882 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

NCT02481830 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957 ·Status: COMPLETED ·Phase: PHASE2

Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.

NCT05128630 ·Status: RECRUITING ·Phase: PHASE2

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

NCT01844791 ·Status: COMPLETED ·Phase: PHASE2